Page 2 - Device Exemption News Today

MedAlliance, the visionary Swiss-based medical technology company has announced the successful acquisition by Cordis, a transaction valued at USD 1.135 billion (Rs. ~ 10,000 Crores). Know details here.

- Presented positive 30-day follow-up results from the C-GUARDIANS U.S. Investigational Device Exemption clinical trial demonstrating an overall major adverse events rate of 0.95% from procedure...

TEL AVIV, Israel and MIAMI, Nov. 01, 2023 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today presented 30-day results from the...

Interim report January- September 2023 XVIVO Perfusion AB Interim report January-September 2023 ...

After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs.

/PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to...

Globus Medical reported Q2 results that beat analyst expectations, upping its full-year sales guidance as it prepares to merge with NuVasive.

AUDUBON, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2023.

25.07.2023 - GOTHENBURG, SWEDEN / ACCESSWIRE / July 25, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The US Food & Drug Administration (FDA) has approved XVIVOs Investigational Device Exemption (IDE) supplement for its heart preservation clinical ...

/PRNewswire/ -- Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc replacement, today...